Zhong Nanshan's team won the 2020 Science and Technology Progress Award Innovation Team Award

Approaching Zhong Nanshan's Respiratory Disease Prevention and Control Innovation Team: Medical research must stand up to the sky, stand up for the people

Approaching the Zhong Nanshan Respiratory Disease Prevention and Control Innovation Team: Medical scientific research must be upright, standing, and for the people

China News Service, Beijing, November 3 (Reporter Li Chun) The 2020 National Science and Technology Awards Conference was held in Beijing on November 3.
Zhong Nanshan's respiratory disease prevention and control innovation team won the National Science and Technology Progress Award Innovation Team
.

Since its establishment in 1979, the team has been guided by the scientific attitude of seeking truth from facts, daring to speak up, and the supremacy of life, with community prevention and control, early diagnosis and treatment, and precise treatment as the starting point, focusing on the epidemiology of the occurrence and development of respiratory diseases.
Research on the key scientific issues of characteristics, molecular mechanisms, early diagnosis and early intervention, has realized the "top heaven", "situation" and "for the people" of medical scientific research
.

The history of the team can be traced back to 1971
.

In response to the call of Premier Zhou Enlai to "strengthen the prevention and treatment of chronic bronchitis and pulmonary heart disease", the First Affiliated Hospital of Guangzhou Medical University established the "Chronic Bronchitis Prevention Team" that year, and its research results won the National Science Conference Award in 1978

Prime Minister

The team is led by Academician Zhong Nanshan , Professor He Jianxing , and Professor Ran Pixin.
There are currently 50 members, 96% of whom are associate professors or above, and 88% have a doctoral degree
.

Team members have successively served as executive directors of the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), president of the Chinese Medical Association, director/deputy director of the Chinese Medical Association Respiratory Society, etc.

Fellow committee member

"Dingtian"-Keep an eye on the international frontiers in areas that are urgently needed by the country

"Dingtian"-Keep an eye on the international frontiers in areas that are urgently needed by the country

Based on domestic actual needs and facing international academic frontiers, Zhong Nanshan's respiratory disease prevention and control innovation team has been benchmarking against the international first-class since its establishment, creating the peak of the domestic respiratory discipline group, and further developing new technologies, new diagnosis and treatment, new methods, and new methods for difficult and severe respiratory diseases.
New drugs
.

In the 42 years, the team has focused on the close combination of clinical and basic research and formed 4 main research directions: the pathogenesis and transmission mechanism of major respiratory infectious diseases and clinical prevention and treatment; minimally invasive treatment system for lung cancer, molecular pathogenesis and early prevention and control; slow resistance The epidemiological characteristics of the lung and its early and comprehensive prevention and control; the molecular epidemiological characteristics, early diagnosis and intervention of allergic diseases
.

In terms of research results, the team has advanced internationally to propose new concepts such as "occult asthma", "full-chain precise and individualized treatment plan for lung cancer," "Tubeless surgery", and "early intervention and comprehensive prevention and control of chronic obstructive pulmonary disease".
An internationally leading model for the prevention and control of sudden respiratory infectious diseases, a postoperative risk prediction model for lung cancer, and a community model for early intervention and comprehensive prevention and control of chronic obstructive pulmonary disease have been constructed
.

What is more noteworthy is that, as the main force in the prevention and treatment of severe respiratory infectious diseases in China, the team has established an internationally advanced "prevention-monitoring-treatment-control" chain cycle management system for major respiratory infectious diseases.
Take the initiative to undertake the arduous task of treating critically ill patients during the epidemic
.

In 2003, Academician Zhong Nanshan said "Send the most critically ill patients to me" a cardiotonic injection into China, which was shrouded in the fog of the SARS epidemic at that time
.

Team defined the pathogenesis of the SARS virus, to achieve the world's highest cure rate (83%); In early 2020, 84-year-old bell academician starry night rush to the rescue Wuhan, the first to identify and propose new crown pneumonia can be transmitted person to person, they crowded dining car rushed to Wuhan The photos moved the whole country

Fellow Fellow

Atypical pneumonia, H1N1, H7N9, Middle East Respiratory Syndrome, New Coronary Pneumonia.
.
.
In the past two decades, team members have been seen in the core work of the prevention and control of major infectious diseases
.

Promoting the construction and development of emergency response mechanisms for public health emergencies, leading to the formulation of a number of national policies and regulations, Zhong Nanshan's respiratory disease prevention and control innovation team has supported the prevention and control of respiratory diseases, especially China's major infectious diseases

"Site"-research and development of prevention, diagnosis and treatment methods and drugs suitable for national conditions

"Site"-research and development of prevention, diagnosis and treatment methods and drugs suitable for national conditions

In 2020, the new crown pneumonia epidemic will sweep the country
.

Guangdong novel coronavirus infection pneumonia epidemic prevention and control technology research group members Cong Feng remember: "The first time a meeting, bell academician stressed 'treatment first, second research', all research should serve to improve the treatment rate And put forward an initiative to'share' scientific research results

academician

Medical research must be able to be implemented and be oriented to clinical needs.
This is the starting point and end point for the team to carry out all the work
.

Focus on solving difficult problems in the field of medical science, and develop disease prevention, diagnosis and treatment methods and drugs suitable for national conditions.

For example, in the field of minimally invasive treatment of lung cancer, one of the four major research directions, the team has established a full-chain minimally invasive radical resection system for lung cancer with tubeless surgery as the core, which is widely used in the prevention, diagnosis, treatment and prognosis of lung cancer; The non-invasive and highly sensitive (80%) screening platform for early lung cancer protects one-third of patients from unnecessary chemotherapy and increases the long-term survival rate of lung cancer by 6%
.

On the one hand, advanced medical technology is transformed into products, and medicines, technologies, and devices suitable for national conditions are developed; on the other hand, clinical diagnosis and treatment norms, consensus, and guidelines formed by advanced experience are promoted to the grassroots level, and through the "applied-feedback- The "correction" mechanism achieves better coverage and application, and the results of scientific research on prevention, diagnosis and treatment have thus been able to sink rapidly and truly land
.

"I'm just a doctor who sees a doctor", this is Zhong Nanshan's evaluation of himself
.

To this day, old academicians who are over eighty years old still sit in the clinic every Thursday afternoon

academician

"For the people"-Committed to improving the health of the people

"For the people"-Committed to improving the health of the people

In 2016, the "One Hundred Thousand Whys of National Health" series led by Zhong Nanshan was officially published
.

The book has important practical significance for the public to conduct self-health management in daily life, practice scientific lifestyles, and improve the health level and health literacy of the whole people, and has produced good social benefits

This is also a result of Zhong Nanshan's respiratory disease prevention and control innovation team promoting health science popularization and improving the national health level
.
The National Respiratory Medicine Center, where the team is located, serves as the clinical transformation base of the Guangzhou National Laboratory.
The national health level contributes more "national team" strength
.

To a certain extent, Zhong Nanshan's "dare to be doctors and speak up" is more out of responsibility for the health and safety of the people
.
In 2003, the sentence "Containment at most, not control" aroused the attention of the whole society to the SARS epidemic; in early 2020, Zhong Nanshan was the first to talk about the phenomenon of human-to-human transmission of new coronary pneumonia in the face of media footage, calling for "No special circumstances, no "Go to Wuhan"; and today, when the epidemic is spreading sporadically, he also proposed that, compared with foreign liberalization, strict epidemic control measures are a low-cost measure for the orderly development of the country; these words are all from the perspective of the health of the whole people
.

Since the 20th century, there have been three waves of coronavirus epidemics around the world, which have had a major impact on human society
.
Faced with the high uncertainty of virus mutations, it will be more challenging to accurately predict the changing trend of the frequency of epidemics in the future
.
The emergence of the epidemic has objectively accelerated the pace of building a healthy China in an all-round way, and the goal of enhancing public health awareness and improving national health is more realistic
.

At the moment, when the focus of China’s health undertakings has shifted from “disease treatment as the center” to “people’s health as the center”, when the new crown pneumonia epidemic is still in a global pandemic, and the dual demands at home and abroad are superimposed, Zhong Nanshan’s respiratory disease The prevention and control innovation team is still unremittingly carrying out basic and clinical scientific research on respiratory diseases, realizing the normalization of the development of new drugs and diagnostic equipment, and escorting the improvement of the overall health of the people
.
As Zhong Nanshan said: "Health is tied to life and life is our original intention; it is our mission to protect the health and safety of the people
.
" (End)